Vivek Purohit Selected Research

XK 469 (XK469)

2/2002

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivek Purohit Research Topics

Disease

3	Alopecia Areata 01/2024 - 01/2023
3	Atopic Dermatitis (Atopic Eczema) 10/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 10/2016
2	Hemophilia A (Haemophilia) 09/2008 - 09/2005
1	Alopecia (Baldness) 01/2023
1	Eczema 04/2020
1	Onychomycosis (Tinea Unguium) 02/2019
1	Pruritus (Itching) 10/2016
1	Hemorrhage 09/2005
1	Neoplasms (Cancer) 02/2002

Drug/Important Bio-Agent (IBA)

3	Janus Kinase 3IBA 01/2024 - 01/2023
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2023
3	Ointments (Pastes)IBA 10/2020 - 10/2016
2	Phosphodiesterase 4 InhibitorsIBA 10/2020 - 04/2020
2	crisaboroleIBA 10/2020 - 04/2020
1	Tyrosine Kinase InhibitorsIBA 01/2024
1	frovatriptan (Allegro)FDA Link 10/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	SaltsIBA 01/2023
1	tavaboroleIBA 02/2019
1	SolutionsIBA 02/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	tofacitinibIBA 10/2016
1	Janus Kinase InhibitorsIBA 10/2016
1	Prostaglandins AIBA 10/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2008
1	Factor VIII (Coagulation Factor VIII)IBA 09/2005
1	XK 469 (XK469)IBA 02/2002
1	matrigelIBA 02/2002
1	Investigational DrugsIBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2023 - 09/2005